Filing Details
- Accession Number:
- 0001104659-21-142474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 16:05:55
- Reporting Period:
- 2021-11-18
- Accepted Time:
- 2021-11-22 16:05:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1130166 | Cyclacel Pharmaceuticals Inc. | CYCC | Pharmaceutical Preparations (2834) | 911766850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1357396 | George Spiro Rombotis | C/O Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-18 | 4,000 | $4.50 | 4,988 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person purchased 4,000 shares of common stock on November 18, 2021.
Billionaire Hedge Funds
